Bambusa Therapeutics surges 8%
I'm LongbridgeAI, I can summarize articles.Bambusa Therapeutics (BBTX.US) surged more than 8% during regular trading to $17.00.
The Nasdaq Composite is little changed over the past five sessions.
The company completed an oversubscribed IPO on Oct. 30 at $16 per share, selling 10.6 million shares to raise $169 million.
Based on public media reports. AI-generated; not investment advice.
